Thank you, Alex. Net sales for the third quarter of fiscal year 2023 were $8.3 million or 28% higher when compared to the same quarter a year ago as we realized a $1.9 million increase in revenue at Ranor. All of the increase in revenue came in the defense markets, offsetting a small decrease in the precision industrial markets. Our defense backlog remains very strong. Cost of sales were $6.8 million or 13% higher than the prior year period due primarily to increased net sales of Ranor and higher unabsorbed overhead of STADCO. Gross profit was $1.5 million or $1 million higher when compared to the same quarter a year ago. Gross profit was higher due primarily to higher revenue and better project mix and strong throughput at Ranor. SG&A expense decreased by $399,000, primarily due to lower spending for outside advisory services. Same quarter a year ago included a onetime cost in connection with the STADCO acquisition. As a result of the above, we recorded operating income of $274,000 compared to operating loss of $1.1 million in the same prior year period. Interest expense for the current quarter and prior year quarter were $94,000. We recorded net income of $134,000 in fiscal 2023 third quarter compared to a net loss of $905,000 in the same period a year ago. Net sales for the 9 months ended December 31, 2022, were $23.9 million compared to $14.7 million in the same period a year ago, an increase of $9.2 million. The sum of additional revenue from our STADCO and Ranor segment were $4.5 million and $4.7 million, respectively. Prior year 9-month period included only about 4 months of STADCO revenue. Our cost of sales for the 9 months ended December 31, 2022, were $7.4 million higher due primarily to the inclusion of the STADCO business for the full 9 months compared to only 4 months of the same period a year ago and a significant increase in net sales of Ranor. Gross profit increased by $1.8 million or 81% higher on a strong operating period at Ranor. Weaker operating results of STADCO from certain unprofitable projects and our production levels dampened consolidated gross margin. SG&A expenses for the 9 months ended December 31, 2022, increased by $897,000, primarily due to the inclusion of STADCO for the full reporting period. As a result of the foregoing, we recorded an operating loss of $371,000 compared to an operating loss of $1.3 million for the prior year. Interest expense was $261,000 for the 9 months ended December 31, 2022, or $79,000 higher than the same prior year period due primarily to a full 9 months of interest expense recorded for the STADCO term loan and higher usage under the revolver loan. We recorded net income of $24,000 for the 9 months ended December 31, 2022, compared to net income of $246,000 for the same period a year ago. The prior year period included a onetime gain of $1.3 million from the loan forgiveness under the Paycheck Protection Program. The current 9-month period included an accrual for $624,000 in the second quarter for refundable employee retention tax credits under the CARES Act. Moving to the cash flows and balance sheet. We realized a cash inflow from operating activities of $871,000 and used $1.3 million for capital expenditures. The total debt was $7.1 million at December 31, 2022, compared to $7.4 million at the end of March 31, 2022, as principal paid on our term loans more than offset additional borrowings under the revolver. Cash balance at December 31, 2022, was $316,000 compared to $1.1 million at March 31, 2022. Working capital was $7.2 million at December 31, 2022, compared to $2.8 million at March 31, 2022, as we extended the Ranor term loan for an additional 5 years in December 2022, and we're able to convert a significant current liability to long term. With that, I will now turn the call back over to Alex.